NAC In US Supplements: Enforcement Discretion Continues, Open Sign Posted On Rulemaking Door
Executive Summary
Final guidance on NAC use in supplements continue FDA's enforcement discretion as agency also notes potential for rulemaking deeming the ingredient a lawful dietary ingredient. But three to five years for a rulemaking is too long, especially when FDA already knows NAC is safe in supplements, industry says.
You may also be interested in...
Consumer Health Products Claiming Treatments For Moles, COVID-19 Back On US FDA Warning Radar
Product sold on Amazon among topical remedies for mole and skin tag removal back on US regulatory radar. Recent warnings show violative COVID-19 claims haven’t disappeared and supplement GMP problems remain common.
It’s Official: US Enforcement Discretion For NAC In Supplements, And Regulatory Options For FDA
Draft guidance states enforcement discretion allowing sales of N-acetyl-L-cysteine supplements which FDA in 2020 ordered firms to halt selling due to its use as a drug ingredient. However, NAC supplements, as they have remained since 2020, were available to US consumers when draft was published.
NAC Gains Tentative Safety Clearance As US Industry Contests FDA's Attempt To Remove It
FDA answers reach supplement industry sounding like a siren that the agency may take same enforcement step it has with NAC with other ingredients long used in supplements. Answers also might not be enough to convince firms to return NAC-containing supplements to their lineups.